Setback For EpiCept

EpiCept Corporation (NASDAQ:EPCT) was dealt a body blow by the US Food and Drug Administration (FDA) recently with the agency rejecting the company’s new drug ...

Tags:

ImmonoGen Drug Gets Orphan Status

ImmunoGen Inc. (NASDAQ:IMGN) recently announced that the US Food and Drug Administration (FDA) granted orphan drug status to the company’s small-cell lung cancer (SCLC) candidate, lorvotuzumab merta...

Tags:

Generic Threat Hanging Over CELG

Celgene Corporation (NASDAQ:CELG) could receive notification shortly regarding a patent challenge for its lead drug Revlimid (lenalidomide) 25 mg capsules. The company announced that according to a po...

Tags:

Integra Recalls Brain Catheters

Medical devices maker Integra LifeSciences Corporation (NASDAQ:IART) has reportedly initiated an urgent global recall of its NeuroBalloon Catheter. The U.S. Food and Drug Administration (FDA) is expec...

Tags:

Good News For Alimera’s Pipeline

Recently, Alimera Sciences’ (ALIM) pipeline received a boost when the US Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for its lead candidate, Iluvien. Furthermore, the ...

Tags:

Unilife TB Syringe Gets FDA OK

Medical devices company Unilife Corporation (UNIS) recently obtained 510 (k) clearance from the U.S. Food & Drug Administration (FDA) for its Unitract Tuberculin (TB) Syringe, a variant of the Uni...

Tags:

Good News For BioMarin’s Pipeline

Recently, BioMarin Pharmaceutical Inc.’s (BMRN) pipeline received a boost with the US Food and Drug Administration (FDA) granting orphan ...

Tags:

Good News For SonoSite

Recently, SonoSite (NASDAQ:SONO) received clearance from US Food and Drug Administration (FDA) for its LumenVu catheter guidance system, which is designed to assist the placement of peripherally inser...

Tags:

Novartis’ Tekamlo Gains FDA Nod

Novartis (NYSE:NVS) recently received a boost with the US Food and Drug Administration (FDA) approving Tekamlo for the treatment of high blood pressure. Tekamlo is a combination of Novartis’ Tekturn...

Tags:

Watson Pharma To Launch New Pill

Watson Pharmaceuticals, Inc. (NYSE:WPI) recently announced its plans to launch Ella, an emergency oral contraceptive (OC) pill that has been approved by the US Food and Drug Administration (FDA) for t...

Tags: